Please login to the form below

Not currently logged in
Email:
Password:

type 1 diabetes

This page shows the latest type 1 diabetes news and features for those working in and with pharma, biotech and healthcare.

FDA approves Sanofi's follow-on version of Lilly’s Humalog

FDA approves Sanofi's follow-on version of Lilly’s Humalog

Admelog is the first FDA-approved follow-on mealtime insulin and has been cleared for use in children older than three and adults with type 1 diabetes, as well as adults ... with type 2 diabetes.

Latest news

More from news
Approximately 6 fully matching, plus 136 partially matching documents found.

Latest Intelligence

  • The rise of real-world evidence The rise of real-world evidence

    Diabeter, a Dutch chain of type 1 diabetes clinics bought by Medtronic in 2015, is an example of this trend. ... and then have it come through a pipe so it populates our practice management system, ”Sue Willman, vice president of global diabetes

  • Taking a lean and careful approach Taking a lean and careful approach

    ulcerative colitis, type 1 diabetes and inflammatory bowel disease. ... This fits well with our mission to tackle unmet needs. Autoimmune conditions are increasing and diabetes is at epidemic levels.

  • Strategic planning in the digital age Strategic planning in the digital age

    In the type 1 diabetes therapy area, healthcare professionals in the UK alone published more than 50, 000 posts on public social media discussing the disease during 2016. ... A study by CREATION of healthcare professional needs in type 1 diabetes,

  • Deal Watch December 2016 Deal Watch December 2016

    Licensor / Acquisition target. Licensee / Acquirer. Deal type. Product /technology. ... Defymed. Not disclosed. Not disclosed. Bio-artificial pancreas for Type 1 diabetes.

  • Opening up innovation Opening up innovation

    With over 1, 000 potential products being worked on, it's on a par with cardiovascular diseases and metabolic disorders in terms of research activity. ... The dream is, if you can develop a medicine that can cure rheumatoid arthritis or can prevent type

More from intelligence
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest appointments

  • JDRF names new CEO JDRF names new CEO

    The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO. ... He now finds himself at the helm of the largest research organisation trying to develop treatment options for type 1 diabetes.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Getting personal with wearable tech

    In partnership with Diabetes UK and Hewlett Packard it is deploying mobile health self-management tools (wearable sensors and software) for people with Type 1 and Type 2 diabetes to

  • JDRF Appeal Video

    JDRF Appeal Video. JDRF video for the Wellington Appeal. JDRF is the type 1 diabetes charity, improving lives until they find the cure. ... They're totally focused on type 1 diabetes, and are run by people with type 1, for people with type 1.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics